An interventional study of Core stability exercise and Myofascial release in Pelvic Girdle Pain, sponsored by Cairo University. Completed at 1 site in Egypt. Open to female participants aged 25 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-12.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
The purpose of this study is to investigate the effect of kinesiotaping on pelvic girdle pain in postpartum women.
Pregnancy-related pain in the SIJ, lumbosacral region, pubic symphysis, or in any combination of these joints has been coined as pelvic girdle pain (PGP) and has been estimated to affect almost half of all pregnant women. Women with PGP have an increased risk of prenatal anxiety, depressive symptoms and postpartum depression compared with healthy pregnant women.
Kinesio Taping is rehabilitative technique used to facilitate the body's natural healing process while providing support and stability to muscles and joints, without restricting their range of motion. Enhanced rehabilitation is thought to be the effect of stimulated reactivation, proprioceptive training, reduced pain, stimulation of correct movement patterns, and reduction of muscle imbalance.
Kinesio Taping (KT) method has been used to decrease and prevent pain in women suffering from pregnancy related low back pain because of increased muscle relaxation while taping is applied. However, there is lack of knowledge regarding the effect of kinesiotaping on PGP in postpartum women.
Therefore, this study will be conducted to provide physiotherapists with a scientific updated knowledge, concerning the effect of kinesiotaping on pain, level of disability and lumbar flexion and extension ROM in pelvic girdle pain in postpartum women, aiming to improve ADLs of postpartum women. This study may expand the role of physiotherapy in women's health
55 studies on the registry are indexed under Pelvic Girdle Pain; 12 are open to participants now.
This study's enrollment of 60 is close to the median of 57 across 39 interventional studies indexed under Pelvic Girdle Pain.
Browse Pelvic Girdle Pain studies →Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The participants will receive core stability exercise and myofascial release for 20 min three times per week for 8 weeks.
Other: Core stability exercise · Other: Myofascial release
The participants will receive kinesiotaping, in addition to core stability exercise and myofascial release for 8 weeks
Other: Core stability exercise · Other: Myofascial release · Other: Kinesiotaping
Lumbo-pelvic stabilizing exercises (posterior pelvic tilt, bilateral hip abduction, bilateral knee raise, bridging, hip shrugging) will be performed three times per week for eight weeks.
The participants will receive myofascial release technique for 20 min for 3 times per week for 8 weeks.
The participants will receive Kinesio-Taping over the sacroiliac joint and the hip region. Following a test trial of a small patch for 24 hours, they will be instructed to keep the tape on for 48 hours (it will be replaced after 48 hours) . It will be applied for 8 weeks.
Assessment of pain
Visual analog scale will be used to assess pain level in each woman in both groups before and after the treatment program. The score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity. The following cut points on the pain VAS have been recommended: no pain (0-4 mm), mild pain (5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm)
Time frame: 8 weeks
Measurement of disability level
The Oswestry disability index will be used to assess function disability. It is a questionnaire consisting of 10 questions about the impact of low back pain on daily life. Unlike other outcome measures in which a higher score is typically a better score, a higher score on the ODI indicates a greater level of disability, according to the following scoring criteria:0-4: No disability; 5-14: Mild disability; 15-24: Moderate disability; 25-34: Severe disability; 35-50: Completely disabled
Time frame: 8 weeks
Assessment of lumbar flexion range of motion (ROM)
Lumbar flexion ROM will be tested by using the inclinometer. The T12 spinous process and the sacral midpoint as landmarks for inclinometer placement. These original landmarks will be modified to the spinal interspaces between T12-L1 and L5-S1 as an attempt to isolate the lumbar spine, and because it was thought that these landmarks are more easily palpated. The trial will begin with the patient in a neutral standing position, with the lumbar spine exposed and feet placed shoulder width apart. The subject will be asked to bend forward as far as possible, keeping their legs straight. This point will be entered as a maximum flexion. Normal lumbar flexion (40-60 degrees).
Time frame: 8 weeks
Assessment of lumbar extension range of motion (ROM)
Lumbar extension ROM will be tested by using the inclinometer. The T12 spinous process and the sacral midpoint as landmarks for inclinometer placement. These original landmarks will be modified to the spinal interspaces between T12-L1 and L5-S1 as an attempt to isolate the lumbar spine, and because it was thought that these landmarks are more easily palpated. The trial will begin with the patient in a neutral standing position, with the lumbar spine exposed and feet placed shoulder width apart. The patient will then be asked to extend back as far as possible with their hands on their hips. This point will be entered as maximal extension. Normal lumbar extension (20-35 degrees).
Time frame: 8 weeks
This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University